Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPP.L Regulatory News (APP)

  • There is currently no data for APP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 - Appreciate Group Plc

21 Nov 2022 17:16

RNS Number : 1179H
Appreciate Group PLC
21 November 2022
 

Form 8 (OPD) - Appreciate Group plc

 

The following amendment has been made to the Form 8 (OPD) announcement released by Appreciate Group plc on 21 November 2022 at 11:59 a.m. under RNS 0893H.

 

Addition of columns titled "Date of Grant", "Normal Vesting Date" and "Expiry Date" and footnote labelled with "*" in section 3 (b).

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Appreciate Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Appreciate Group plc

(d) Is the discloser the offeror or the offeree?

Offeree

(e) Date position held:

The latest practicable date prior to the disclosure

21 November 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a)

Name

Number of Ordinary Shares

% of total issued share capital of Appreciate Group

Appreciate Group Directors

Guy Parsons

56,413

0.03

Sally Cabrini

35,000

0.02

John Gittins

10,000

0.01

 

b)

Appreciate Group Director

Number of Appreciate Group Shares under Option

Date of Grant

Exercise Price

Normal Vesting Date

Expiry Date

Julian Coghlan

183,004

199,038

389,948

22 June 2021

16 June 2022

22 June 2022

£0.00

£0.00

£0.00

 

22 June 2024

16 June 2025

*

22 June 2031

16 June 2032

22 June 2032

 

*2nd anniversary of the date of grant in respect of 40% of the Shares under Option and 3rd anniversary of the date of grant in respect of 60% of the Shares under Option.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

21 November 2022

Contact name:

Talha Ahmed

Telephone number:

020 3128 8193

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEAXFFAFDAFFA
Date   Source Headline
1st Mar 20237:00 amRNSCancellation - Appreciate Group plc
28th Feb 20232:27 pmGNWADMISSION OF CONSIDERATION SHARES
28th Feb 20231:00 pmRNSForm 8.3 - APPRECIATE GROUP PLC
28th Feb 202310:05 amRNSForm 8.3 - Appreciate Group plc / PayPoint plc
28th Feb 20239:05 amGNWPaypoint Completes Acquisition of Appreciate Group
28th Feb 20239:00 amRNSScheme of Arrangement becomes effective
28th Feb 20237:30 amRNSSuspension - Appreciate Group PLC
27th Feb 202310:06 amRNSForm 8.3 -APPRECIATE GROUP PLC
27th Feb 20239:44 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
24th Feb 20232:08 pmRNSForm 8.3 - Paypoint Plc
24th Feb 20231:33 pmRNSForm 8.3 - APPRECIATE GROUP PLC
24th Feb 202311:21 amRNSForm 8.3 - APPRECIATE GROUP PLC
24th Feb 20239:56 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
24th Feb 20239:33 amRNSForm 8.5 (EPT/RI)
24th Feb 20239:21 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
23rd Feb 202312:34 pmRNSExercise of Options
23rd Feb 202312:11 pmRNSForm 8.3 - APPRECIATE GROUP PLC
23rd Feb 202312:04 pmRNSCourt Sanction of the Scheme of Arrangement
23rd Feb 202311:10 amRNSForm 8.3 -APPRECIATE GROUP PLC
23rd Feb 20239:37 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
23rd Feb 20239:17 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
22nd Feb 20233:30 pmRNSForm 8.3 - APP LN
22nd Feb 20231:25 pmRNSForm 8.3 - APPRECIATE GROUP PLC
22nd Feb 20239:17 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
21st Feb 20235:45 pmRNSPayPoint
21st Feb 20234:01 pmRNSForm 8.3 - PAY LN
21st Feb 20234:00 pmRNSForm 8.3 - APP LN
21st Feb 202312:20 pmRNSForm 8.3 - APPRECIATE GROUP PLC
21st Feb 20239:18 amRNSForm 8.3 - Appreciate Group plc / PayPoint plc
20th Feb 20233:30 pmRNSForm 8.3 - APP LN
20th Feb 20233:30 pmRNSForm 8.3 - PAY LN
20th Feb 20238:48 amRNSForm 8.5 (EPT/RI)
17th Feb 20233:30 pmRNSForm 8.3 - APP LN
17th Feb 20232:55 pmRNSForm 8.3 - APPRECIATE GROUP PLC
16th Feb 20232:36 pmRNSForm 8.3 - PAYP LN
16th Feb 20232:35 pmRNSForm 8.3 - APP LN
16th Feb 202312:28 pmRNSForm 8.3 - APPRECIATE GROUP PLC
16th Feb 202310:09 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
16th Feb 20238:41 amRNSForm 8.3 - Appreciate Group PLC
15th Feb 20232:23 pmRNSForm 8.3 - APPRECIATE GROUP PLC
15th Feb 202310:30 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
15th Feb 20238:34 amRNSForm 8.5 (EPT/RI)
15th Feb 20238:33 amRNSForm 8.3 - APPRECIATE GROUP PLC
14th Feb 20235:12 pmRNSHolding(s) in Company
14th Feb 20232:38 pmRNSForm 8.3 - APPRECIATE GROUP PLC
14th Feb 20232:30 pmRNSForm 8.3 - APP LN
14th Feb 20239:38 amRNSForm 8.3 - Appreciate Group plc / Paypoint plc
14th Feb 20239:23 amRNSForm 8.5 (EPT/RI)
13th Feb 202311:50 amRNSForm 8.3 - Appreciate Group Plc
13th Feb 202311:43 amRNSForm 8.3 - APPRECIATE GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.